Tags

Type your tag names separated by a space and hit enter

Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry.
Neurochem Int 2005; 47(5):350-61NI

Abstract

Illicit use of p-methoxyamphetamine (PMA) is rapidly increasing. However, little is known about the acute effects of PMA on neurotransmission in vivo. High-speed chronoamperometry was used to monitor neurotransmitter release and clearance in anesthetized rats after local application of PMA or 3,4-methylenedioxymethamphetamine (MDMA). In striatum, PMA caused less neurotransmitter release than MDMA. PMA-evoked release could be partially blocked by pre-treatment with a serotonin (5-HT) reuptake inhibitor, suggesting that evoked 5-HT release contributed to the electrochemical signal and was mediated by the 5-HT transporter (SERT). MDMA-evoked release was not blocked by a SERT inhibitor, suggesting that primarily DA was released. To study the effect of these amphetamines on clearance of 5-HT mediated specifically by the SERT, clearance of exogenously applied 5-HT was measured in the CA3 region of the hippocampus. In contrast to the striatum where 5-HT is cleared by both the SERT and the dopamine transporter (DAT), 5-HT is cleared primarily by the SERT in the CA3 region. This is also a region where neither PMA nor MDMA evoked release of neurotransmitter. The maximal inhibition of 5-HT clearance was greater after PMA than MDMA. These data demonstrate in vivo (1) brain region variability in the ability of PMA and MDMA to evoke release of neurotransmitter; (2) that clearance of 5-HT in the striatum is mediated by both the SERT and the DAT; (3) distinct differences in the amount and nature of neurotransmitter released in the striatum after local application of PMA and MDMA and (4) that PMA is a more efficacious inhibitor of 5-HT clearance in the hippocampus than MDMA. These fundamental differences may account for the more severe adverse reactions seen clinically after PMA, compared to MDMA.

Authors+Show Affiliations

Department of Physiology, The University of Texas Health Science Center at San Antonio, San Antonio, 78229-3900, USA.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

15979209

Citation

Callaghan, Paul D., et al. "Differences in the in Vivo Dynamics of Neurotransmitter Release and Serotonin Uptake After Acute Para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine Revealed By Chronoamperometry." Neurochemistry International, vol. 47, no. 5, 2005, pp. 350-61.
Callaghan PD, Irvine RJ, Daws LC. Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. Neurochem Int. 2005;47(5):350-61.
Callaghan, P. D., Irvine, R. J., & Daws, L. C. (2005). Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. Neurochemistry International, 47(5), pp. 350-61.
Callaghan PD, Irvine RJ, Daws LC. Differences in the in Vivo Dynamics of Neurotransmitter Release and Serotonin Uptake After Acute Para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine Revealed By Chronoamperometry. Neurochem Int. 2005;47(5):350-61. PubMed PMID: 15979209.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. AU - Callaghan,Paul D, AU - Irvine,Rodney J, AU - Daws,Lynette C, PY - 2004/09/09/received PY - 2005/01/20/revised PY - 2005/04/06/accepted PY - 2005/6/28/pubmed PY - 2005/9/9/medline PY - 2005/6/28/entrez SP - 350 EP - 61 JF - Neurochemistry international JO - Neurochem. Int. VL - 47 IS - 5 N2 - Illicit use of p-methoxyamphetamine (PMA) is rapidly increasing. However, little is known about the acute effects of PMA on neurotransmission in vivo. High-speed chronoamperometry was used to monitor neurotransmitter release and clearance in anesthetized rats after local application of PMA or 3,4-methylenedioxymethamphetamine (MDMA). In striatum, PMA caused less neurotransmitter release than MDMA. PMA-evoked release could be partially blocked by pre-treatment with a serotonin (5-HT) reuptake inhibitor, suggesting that evoked 5-HT release contributed to the electrochemical signal and was mediated by the 5-HT transporter (SERT). MDMA-evoked release was not blocked by a SERT inhibitor, suggesting that primarily DA was released. To study the effect of these amphetamines on clearance of 5-HT mediated specifically by the SERT, clearance of exogenously applied 5-HT was measured in the CA3 region of the hippocampus. In contrast to the striatum where 5-HT is cleared by both the SERT and the dopamine transporter (DAT), 5-HT is cleared primarily by the SERT in the CA3 region. This is also a region where neither PMA nor MDMA evoked release of neurotransmitter. The maximal inhibition of 5-HT clearance was greater after PMA than MDMA. These data demonstrate in vivo (1) brain region variability in the ability of PMA and MDMA to evoke release of neurotransmitter; (2) that clearance of 5-HT in the striatum is mediated by both the SERT and the DAT; (3) distinct differences in the amount and nature of neurotransmitter released in the striatum after local application of PMA and MDMA and (4) that PMA is a more efficacious inhibitor of 5-HT clearance in the hippocampus than MDMA. These fundamental differences may account for the more severe adverse reactions seen clinically after PMA, compared to MDMA. SN - 0197-0186 UR - https://www.unboundmedicine.com/medline/citation/15979209/Differences_in_the_in_vivo_dynamics_of_neurotransmitter_release_and_serotonin_uptake_after_acute_para_methoxyamphetamine_and_34_methylenedioxymethamphetamine_revealed_by_chronoamperometry_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0197-0186(05)00118-X DB - PRIME DP - Unbound Medicine ER -